Variant report
Variant | esv21397 |
---|---|
Chromosome Location | chr20:1238750-1241117 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:1227236..1231835-chr20:1234457..1238851,4 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527313756 | chr20:1238760-1238761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546964170 | chr20:1238842-1238843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187494290 | chr20:1238844-1238845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191109478 | chr20:1238852-1238853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570084012 | chr20:1238861-1238862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142721096 | chr20:1238864-1238865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552412771 | chr20:1238872-1238873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116043617 | chr20:1238880-1238881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147355278 | chr20:1238886-1238887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544290417 | chr20:1238906-1238907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs75831123 | chr20:1238920-1238921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111805088 | chr20:1238942-1238943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555085186 | chr20:1238952-1238953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs79707373 | chr20:1238978-1238979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs76064377 | chr20:1238983-1238984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1294732 | chr20:1238988-1238989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1294734 | chr20:1238999-1239000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368972541 | chr20:1239005-1239006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs805566 | chr20:1239032-1239033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs805572 | chr20:1239041-1239042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs805564 | chr20:1239046-1239047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs809289 | chr20:1239047-1239048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs202175684 | chr20:1239048-1239049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs805567 | chr20:1239051-1239052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1294735 | chr20:1239095-1239096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376577860 | chr20:1239104-1239105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs35494868 | chr20:1239109-1239110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574822756 | chr20:1239111-1239112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78184736 | chr20:1239131-1239132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534213559 | chr20:1239133-1239134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs62187486 | chr20:1239194-1239195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373876279 | chr20:1239230-1239231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554232004 | chr20:1239234-1239235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560993678 | chr20:1239251-1239252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs805568 | chr20:1239257-1239258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs368825487 | chr20:1239284-1239285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372942184 | chr20:1239293-1239294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs813124 | chr20:1239298-1239299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371623263 | chr20:1239300-1239301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577277440 | chr20:1239303-1239304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs805569 | chr20:1239314-1239315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs62187487 | chr20:1239320-1239321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs805565 | chr20:1239323-1239324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs376276604 | chr20:1239347-1239348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370655145 | chr20:1239356-1239357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374049178 | chr20:1239361-1239362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs367883356 | chr20:1239383-1239384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs370448794 | chr20:1239386-1239387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs370478845 | chr20:1239410-1239411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79565242 | chr20:1239419-1239420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17603634 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 17363583 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:1238000-1239000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr20:1239000-1239800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |